North America: Intellectual Property

Subscribe
Intellectual property law and copyright law thought leadership, articles, podcasts, videos and webinars from expert sources across the legal world. Explore insights covering topics such as licensing and syndication, patent law, trade secrets and trademark law.
Article
UK High Court Upholds Takeda’s Lisdexamfetamine SPC: Will The CJEU Agree?
The UK High Court has ruled on whether lisdexamfetamine (LDX), a pro-drug with no therapeutic activity before conversion to dextroamphetamine, can be considered an "active ingredient" for supplementary protection certificate purposes. This decision addresses a critical question in pharmaceutical patent law that has produced divergent outcomes across European jurisdictions and is currently before the CJEU in multiple pending referrals.
United States IP
JA
J A Kemp LLP
See more
Article
AI-Assisted Inventions: Human Inventorship And USPTO Disclosure Duties
Quick Answer: AI-assisted inventions use the same U.S. inventorship standard as other inventions, with only human beings eligible as inventors. Technology companies should document each person's conception of the claimed invention before drafting claims and approving inventor declarations. The USPTO imposes no general AI-use disclosure duty, but information material to patentability can still require disclosure. [2] Patent counsel should assess inventorship, disclosure, and eligibility separately before the company commits to a filing strategy.
United States Technology
Novak Druce Carroll
Article
UK High Court Upholds Takeda’s Lisdexamfetamine SPC: Will The CJEU Agree?
The UK High Court has ruled on whether lisdexamfetamine (LDX), a pro-drug with no therapeutic activity before conversion to dextroamphetamine, can be considered an "active ingredient" for supplementary protection certificate purposes. This decision addresses a critical question in pharmaceutical patent law that has produced divergent outcomes across European jurisdictions and is currently before the CJEU in multiple pending referrals.
United States IP
JA
J A Kemp LLP
Article
The AI Tools Speeding Up Drug Discovery Come With Risky Fine Print
Researchers routinely use AI tools like AlphaFold and Schrödinger's software without scrutinizing license agreements that contain restrictions on commercial use, confidentiality, and mandatory disclosure requirements. These overlooked terms can create significant legal obstacles when translating academic innovations into commercial products, affecting everything from sponsored research agreements to patent filings and university spinouts.
United States IP
FH
Foley Hoag LLP
See more
Article
The AI Tools Speeding Up Drug Discovery Come With Risky Fine Print
Researchers routinely use AI tools like AlphaFold and Schrödinger's software without scrutinizing license agreements that contain restrictions on commercial use, confidentiality, and mandatory disclosure requirements. These overlooked terms can create significant legal obstacles when translating academic innovations into commercial products, affecting everything from sponsored research agreements to patent filings and university spinouts.
United States IP
FH
Foley Hoag LLP
Article
Patents In Canada: A Practical Guide For Foreign Businesses
Canadian patent law contains distinct procedural and substantive requirements that can significantly affect claim scope, prosecution costs, patent term, and enforceability for foreign companies. Understanding these differences—from software patentability standards to patent term adjustment opportunities—is essential for developing an effective North American IP strategy that maximizes protection while controlling costs.
Canada IP
MT
Miller Thomson LLP
Article
AI In The Art Market, Part 3: Human Creativity And Authenticity
As AI-generated art becomes increasingly sophisticated and visible in institutions like Dataland, the art world grapples with fundamental questions about distinguishing human creativity from machine output. This analysis explores the legal, commercial, and reputational implications for copyright protection, market positioning, disclosure obligations, and the evolving regulatory landscape surrounding AI use in creative industries.
United States IP
HK
Holland & Knight
See more
Article
How Can Companies Correctly Trademark NFTs And Web Products Under Updated TMEP Rules?
The USPTO imposes exacting identification requirements for Web3, gaming, and virtual media trademarks. Under TMEP § 1401.15(b), applicants cannot identify goods or services simply as "NFTs" or "virtual goods" because those terms do not describe recognizable items in commerce under the Trademark Act. To obtain trademark protection, applicants must clearly describe the asset underlying the digital representation, how it will be delivered, and how it is intended to be used.
United States IP
G
Gamma Law
Article
Pepsi Case Could Reshape How Courts Judge Trademark Strength
A U.S. Supreme Court review of Rise Brewing's trademark infringement case against PepsiCo could fundamentally alter who determines brand strength in trademark disputes. The case examines whether judges or juries should assess trademark distinctiveness, with implications for how businesses select and enforce their marks. Existing marks and registration statements may significantly impact a company's ability to protect its trademark rights.
United States IP
MG
Marshall, Gerstein & Borun LLP
See more
Article
Texas Court Of Appeals Affirms Business Court’s Denial Of Trade Secret Injunction In Autonomous Trucking Dispute
In CreateAI Holdings, Inc. f/k/a TuSimple Holdings, Inc. v. Bot Auto TX Inc., the Fifteenth Court of Appeals affirmed a Texas Business Court’s denial of a temporary injunction in an autonomous trucking trade secret dispute. The court’s memorandum opinion recognizes that mere suspicion and a competitor’s rapid success are insufficient to warrant injunctive relief. Instead, plaintiffs must produce evidence that specific, protectable secrets existed and were actually misappropriated.
United States IP
GT
Greenberg Traurig, LLP
Article
USPTO And Federal Circuit Decisions Reveal Patent Eligibility Parameters For AI Use
As businesses rapidly adopt artificial intelligence, machine learning, and predictive analytics across their operations, many overlook critical intellectual property considerations. Recent federal court decisions reveal the nuanced distinction between simply automating existing processes with AI versus creating patentable innovations that improve how AI systems themselves operate.
United States IP
RB
Reinhart Boerner Van Deuren s.c.
See more